Investigative therapies to treat moderate to severe plaque psoriasis in clinical trials include several orally administered ...

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') is pleased to announce that the New Drug Application (NDA) of its internally-developed IL-17-targeting monoclonal antibody gumokimab (AK111) has been ...

If you've ever suffered from common skin conditions like rosacea, eczema or psoriasis, you know how uncomfortable the itching ...

Jack Danilkowicz appointed as Chief Commercial Officer; bringing extensive experience successfully planning and executing commercial strategies ...

The pharmaceutical industry could generate more than $1.2 trillion in global sales in 2025, according to Statista. The cancer segment alone is expected to generate $208 billion in sales this year.

As the 119th Congress convenes, policymakers have a historic opportunity to lower prescription drug prices for Americans. As members of Congress begin negotiating the continuing resolution set for ...

Research uncovers how different types of light transform your skin, with experts warning about hidden dangers and unexpected ...

Think twice before applying turmeric to your face! While turmeric has its benefits, our expert reveals five compelling ...

We’ll discuss the distinct traits of psoriatic arthritis in Black patients, and the various environmental and genetic factors ...

The point is that we generally consider light to be good, safe, even comforting. Yet when it comes to our skin, things are a ...

Dirty hair pain can be annoying, but it's easy to fix. Here's what causes it and how you can make it go away, according to ...

StockNews.com assumed coverage on shares of Can-Fite BioPharma (NYSE:CANF – Free Report) in a research report report published on Sunday morning. The brokerage issued a sell rating on the stock.